InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
70.90
(
0.00%
)
Bitcoin
91,454.44
(
0.43%
)
Post# of 158400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Inoviorulez

Send PM Follow Ignore
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Inoviorulez

Re: Sooah post# 80265

Sunday, 06/23/2013 9:50:47 PM

Sunday, June 23, 2013 9:50:47 PM

Post# of 158400
I liked what you wrote but I will have to disagree with needing more than 10. You might ask why??? Simply because this is only a phase 1 trial!

The majority of biotechs start off phase 1 with a small sample size 10 to 20 just to test the efficacy and safety slightly. Once it gets to phase 2 then they enroll 100 to 150 and then in phase 3 normally there is 300 or more patients enrolled. It's always been like this. It is not uncommon for phase 1 to only have 10 patients as a sample size!
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up